589. Why Has the Opioid Crisis Lasted So Long?

Episode Summary

Executive Summary: The episode examines why the opioid epidemic keeps worsening despite harm reduction, treatment, law enforcement, and settlement money. Using research by David Cutler and Travis Donahoe, it argues that opioid use spreads through social spillovers and easy access, while fentanyl’s potency and the legal/black-market supply chain make deaths persist. Keith Humphreys adds that prevention, treatment, regulation, and selective stigma may be necessary.

Main Topics: Why the opioid epidemic persists (Priority: 5/5): The show asks why opioid deaths have continued rising for decades even after multiple policy responses, suggesting that earlier solutions have not been sufficient to break the cycle. Social contagion and spillover effects (Priority: 5/5): Cutler and Donahoe argue opioid use spreads through networks, geography, and online/social ties, creating feedback loops where current users generate new users. Fentanyl and the changing drug supply (Priority: 5/5): The episode explains how fentanyl’s low production cost, high potency, and ease of shipment have transformed the market and raised overdose risk dramatically. Harm reduction vs. stigma (Priority: 4/5): Humphreys defends naloxone, syringe service programs, and treatment while also arguing that some stigma can serve as a useful social signal against harmful drug use. Failures of decriminalization and limits of policy (Priority: 4/5): Oregon’s decriminalization experiment is presented as evidence that removing penalties alone does not create recovery or reduce harm in the way advocates hoped. Prevention, treatment, and youth interventions (Priority: 4/5): The episode emphasizes early prevention, stronger medical regulation, and chronic-disease-style addiction care as the most promising long-term responses.

Key Arguments: Opioid deaths keep rising because the epidemic has become self-reinforcing: users often introduce other users, and nearby/socially connected communities experience spillover. A major driver is not just despair or pain, but the social availability of opioids and the ease with which they are shared, sold, or recommended. Fentanyl has made the crisis more lethal because it is cheap, compact, easy to ship, and dangerously variable in potency from batch to batch. Deaths are not a perfect measure of demand; rising fatalities may reflect higher risk per use rather than more users. Harm reduction measures like naloxone and syringe services save lives, but they do not solve the underlying market and behavioral dynamics. Decriminalization alone is insufficient because drug use produces immediate reward, while the social and legal pressures that sometimes push people toward treatment remain important. The best long-term strategy combines prevention in youth, better addiction treatment, tighter control of legal prescribing, and targeted disruption of open-air drug markets and probation/parole populations. Some stigma can function like public-health signaling, similar to modern attitudes toward drunk driving or domestic violence, without reverting to punitive incarceration for mere use.

Data Points: Drug overdose deaths (2017): about 70,000 - Referenced as the scale of the U.S. overdose crisis in the earlier opioid series. Increase in opioid prescriptions/use: about 5x - Described as the growth in opioid supply and use from the mid-1990s through roughly 2010. U.S. adults with at least one opioid prescription filled (2017): 57 million - CDC estimate cited to show how widespread legal opioid exposure remains. Share of U.S. population with an opioid prescription in 2017: nearly 20% - Same CDC figure used to underscore the size of the legal market. Estimated contribution of spillovers to opioid deaths: roughly 90% - Cutler and Donahoe’s estimate that social contagion explains most opioid mortality growth. Median age of first opioid use: 12 to 14 - Mentioned as the typical age range when initiation often begins. People who abuse opioids getting them free from friends or relatives: roughly half - Government survey figure cited in the discussion of diversion from households/social networks. Fentanyl consumption entering the U.S.: about 5 to 10 metric tons per year - Estimate referenced to show how little physical volume is needed to supply the market. South Dakota 24-7 Sobriety success rate: 99.1% - Proportion of alcohol tests showing sobriety in the program Keith Humphreys discussed. 24-7 Sobriety tests conducted in South Dakota: over 10 million - Used to illustrate the scale and durability of the program. New York City drug users testing positive for fentanyl: more than 4 out of 5 - Study cited to show fentanyl contamination across street drugs. New York City drug users intentionally using fentanyl: only 1 out of 5 - Shows much fentanyl exposure is unintended. Annual cigarette-related deaths worldwide: 8 million - Humphreys used this to compare the scale of legal-drug mortality with illicit drugs.

Pivotal Quotes: "It’s horrible. It’s absolutely horrifying." — Keith Humphreys: His reaction to the continued rise in annual opioid deaths despite multiple interventions. "Depression feels bad every day. Drug use doesn’t feel bad. Drug use feels incredible." — Keith Humphreys: Explains why removing stigma or pressure may not reduce use the way advocates hope. "Spillovers, they write, are the main reason deaths have increased for so long." — David Cutler / Travis Donahoe: Summarizes the central finding of their paper on social contagion in opioid use.

Implications: The crisis is unlikely to improve through single fixes. Listeners should expect a mix of prevention, treatment, tighter prescribing, targeted enforcement, and harm reduction. For policymakers, the key is breaking social and supply-chain feedback loops.